Brian Vastag on Nostr: Pharma company BioVie announces phase 2 trial of investigational new drug for ...

Pharma company BioVie announces phase 2 trial of investigational new drug for #LongCovid. The drug candidate, bezesterim, is also being tested in patients with Alzheimer's & Parkinson's diseases. The company says it crosses the blood-brain barrier & reduces neuroinflammation, which is often seen in long covid.

It's being funded by DOD.

https://finance.yahoo.com/news/biovie-announces-fda-authorization-investigational-120000163.html